Effects of Smad7 overexpression on peritoneal inflammation in a rat peritoneal dialysis model

Peritoneal Dialysis International

Volumn 27, Issue 5, 2007, Pages 580-588

  Nie, Jing ^a   Hao, Wenke ^a   Dou, Xianrui ^a   Wang, Xin ^a   Luo, Ning ^a   Lan, Hui Y ^b   Yu, Xueqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Gene transfer; Inflammatory cells; Proinflammatory cytokines; Smad7; TGF

Indexed keywords

DOXYCYCLINE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; SMAD7 PROTEIN, RAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIALYSATE; DISEASE ASSOCIATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE TRANSFER; IMMUNOFLUORESCENCE; INFLAMMATION; INFLAMMATORY CELL; LYMPHOCYTIC INFILTRATION; MACROPHAGE ACTIVATION; MALE; MICROBUBBLE; NONHUMAN; PERITONEAL DIALYSIS; PERITONEUM MACROPHAGE; PERITONITIS; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; ULTRASOUND; UPREGULATION; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; DRUG ANTAGONISM; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; GENE TRANSFER TECHNIQUES; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MALE; PERITONEAL DIALYSIS; PERITONITIS; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 38449119268     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080702700520     Document Type: Article

References (31)

1. Di Paolo N, Sacchi G. Atlas of peritoneal histology. Perit Dial Int 2000; 20(Suppl 3):S5-96.
2. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI. What really happens to people on Long-term peritoneal dialysis? Kidney Int 1998; 54:2207-17.
3. Williams JD, Craig KJ, Topley N, Von Ruhland C, Fallon M, Newman GR, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13:470-9.
4. Honda K, Nitta K, Horita S, Yumura W, Nihei H, Nagai R, et al. Accumulation of advanced glycosylation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 1999; 14:1541-9.
5. Coles GA, Topley N. Long-term peritoneal membrane changes. Adv Ren Replace Ther 2000; 7:289-301.
6. Wang HH, Lin CY. Effect of repeated peritonitis on peritoneal membrane function in children on chronic peritoneal dialysis. Zhonghua Yi Xue Za Zhi (Taipei) 2002; 65:205-11.
7. Lai KN, Lai KB, Lam CW, Chan TM, Li FK, Leung JC. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2000; 35:644-52.
8. Margetts PJ, Kolb M, Yu L, Hoff CM, Holmes CJ, Anthony DC, et al. Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum. Am J Pathol 2002; 160: 2285-94.
9. Zhu Z, Yao J, Wang F, Xu Q. TNF-alpha and the phenotypic transformation of human peritoneal mesothelial cell. Chin Med J 2002; 115:513-17.
10. Margetts; PJ, Kolb M, Galt T, Hoff CM, Shockley TR, Gauldie J. Gene transfer of transforming growth factor beta 1 to the rat peritoneum: effects on membrane function. J Am Soc Nephrol 2001; 12:2029-39.
11. Oh KH, Margetts PJ. Cytokines and growth factors in peritoneal fibrosis of peritoneal dialysis patients. Int J Artif Organs 2005; 28:129-34.
12. Breborowicz A, Oreopoulos G. Evidence for the presence of chronic inflammation during peritoneal dialysis: therapeutic implications. Perit Dial Int 1997; 17(Suppl 2): S37-41.
13. Mlambo NC, Hylander B, Brauner A. Increased levels of transforming growth factor β1 and basic fibroblast growth factor in patients on CAPD: a study during non-infected steady state and peritonitis. Inflammation 1999; 23: 131-9.
14. Wang T, Ghen YG, Ye RG, Mai WY, Zhen ZH, Li HQ. Enhanced expression of TGFβ1 by peritoneal macrophages in CAPD patients. Adv Perit Dial 1995; 11:11-14.
15. Lai KN, Lai KB, Szeto CC, Lam CWK, Leung JCK. Growth factors in continuous ambulatory peritoneal dialysis effluent. Am J Nephrol 1999; 19:416-22.
16. Dou XR, Yu XQ, Li XY, Chen WF, Hao WK, Jia ZJ, et al. The role of TGF-beta1/Smads in the development of peritoneal fibrosis induced by high glucose peritoneal dialysate and LPS [in Chinese]. Zhonghua Yi Xue Za Zhi 2005; 85: 2613-18.
17. Piek E, Heldin CH, Ten DP. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 1999; 13:2105-124.
18. Massagué J, Wotton D. Transcriptional control by the TGF-β/ Smad signating system. EMBO J 2000; 19:1745-54.
19. Derynck R, Zhang Y, Feng XH. Transcriptional activators of TGF-β responses: Smads. Cell 1998; 95:737-40.
20. Ng YY, Hou CC, Wang W, Huang XR, Lan HY. Blockade of NFκB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney. Kidney Int Suppl 2005; 94:S83-91.
21. Wang W, Huang XR, Li AG, Liu F, Li JH, Truong LD, et al. Signaling mechanism of TGF-β1 in prevention of renal inflammation: role of Smad7. J Am Soc Nephrol 2005; 16: 1371-83.
22. Lan HY, Mu W, Tomita N, Huang XR, Li JH, Zhu HJ, et al. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 2003; 14:1535-48.
23. Philpott DJ, Yamaoka S, Israel A, Sansonetti PJ. Invasive Shigella flexneri activates NF-kappa B through a Lipopolysaccharide dependent innate intracellular response and leads to IL-8 expression in epithelial cells. J Immunol 2000; 165:903-14.
24. Jayne DG, Perry SL, Morrison E, Farmery SM, Guillou PJ. Activated mesothelial cells produce heparin-binding growth factors: implications for tumor metastases. Br J Cancer 2000; 82:123 3-8.
25. Tewis B, Bauch A, Ruffner H, Angrand PO, Bergamini G, Croughton K, et al. A physical and functional map of the human TNF-α/ NF-κB signal transduction pathway. Nat Cell Biol 2004; 6:97-105.
26. Yang WS, Kim BS, Lee SK, Park JS, Kim SB. Interleukin-1β stimulates the production of extracellular matrix in cultured human peritoneal mesothelial cells. Perit Dial Int 1999; 19:211-20.
27. Flanders KC. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 2004; 85:47-64.
28. Takagawa S, Lakos G, Mori Y, Yamamoto T, Nishioka K, Varga J. Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma. J Invest Dermatol 2003; 121:41-50.
29. Tamaki K, Okuda S. Role of TGF-beta in the progression of renal fibrosis. Contrib Nephrol 2003; 139:44-65.
30. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992; 359(6397):693-9.
31. Hou CC, Wang W, Huang XR, Sheihk-Hamad D, Lan HY. Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks TGF-β signaling and fibrosis in rat remnant kidney. Am J Pathol 2005; 166:761-71.